| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC2435 | |||||||||||||||||||||||
| Submitter : | Mrs. Sharon Harrigan | Date & Time: | 12/01/2006 08:12:57 | |||||||||||||||||||||
| Organization : | Mrs. Sharon Harrigan | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| It is unacceptable to use cell lines from aborted fetal tissue when there are other viable acceptable alternatives available. Please do not approve the use of these cell lines when making vaccines. | ||||||||||||||||||||||||